Table 1 Demographic and clinical characteristics of stable hemodialysis patients enrolled in crude analysis

Number of patients

631

Deaths during follow-up, n (%)

194 (30.7%)

Deaths in cardiovascular disease, n (%)

72 (11.4%)

Age, years

61.1 ± 12.2

Female, n (%)

236 (37.4%)

Diabetic nephropathy, n (%)

126 (20.0%)

Hemodialysis duration, months

110.1 ± 86.2

Body mass index, kg/m²

22.2 ± 3.2

Kt/V

1.51 ± 0.26

Cumu. mean predia. β₂-M, mg/L

28.7 ± 5.3

Normalized PCR, g/kg/day

1.01 ± 0.18

Creatinine generation rate, %

100.7 ± 22.2

WBC count, 10³/μL

6.09 ± 1.81

Hemoglobin, g/dL

10.6 ± 1.1

Hematocrit, %

32.4 ± 3.6

Platelet count, 10³/μL

192.6 ± 56.8

Albumin, g/dL

3.66 ± 0.34

Urea nitrogen, mg/dL

75.3 ± 15.9

Uric acid, mg/dL

7.72 ± 1.18

Creatinine, mg/dL

11.4 ± 2.8

Mean predialysis sodium, mEq/L

139.9 ± 2.8

Potassium, mEq/L

4.86 ± 0.69

Calcium, mg/dL

9.83 ± 0.79

Phosphate, mg/dL

5.16 ± 1.12

Mean interdialytic weight gain, % of DW

4.52 ± 1.31

Actual follow-up period, months

68.3 ± 23.3